Extracts from the history and medical properties of garlic

Pharmacognosy Reviews

Volumn 4, Issue 7, 2010, Pages 106-110

  Petrovska, Biljana ^a   Cekovska, Svetlana ^b  

^a Faculty of Pharmacy   (France)

^b SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Allium sativum; garlic; history; usage

Indexed keywords

AJOENE; ALLICIN; ALLIIN; GARLIC EXTRACT;

ACUTE GRANULOCYTIC LEUKEMIA; ALOPECIA; ALZHEIMER DISEASE; ANTIBACTERIAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIPYRETIC ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; CHOLERA; CHRONIC BRONCHITIS; COLIC; COMMON COLD; COUGHING; DANDRUFF; DEMENTIA; DIPHTHERIA; DOG BITE; DRUG MECHANISM; ESSENTIAL HYPERTENSION; FEVER; GANGRENE; HEART PROTECTION; HELMINTHIASIS; HEMORRHOID; HISTORY OF MEDICINE; HUMAN; HYPERTENSION; INFLUENZA; JAUNDICE; MEDICINAL PLANT; MYOSITIS; NONHUMAN; PHARMACIST; PHYSICIAN; RECOMMENDED DRUG DOSE; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATIC DISEASE; SARCOMA; SKIN DISEASE; SNAKEBITE; SPIDER BITE; STOMACH PAIN; TUBERCULOSIS; TYPHOID FEVER; ULCER; WEAKNESS;

ALLIUM SATIVUM;

EID: 77955700877     PISSN: None     EISSN: 09737847     Source Type: Journal    
DOI: 10.4103/0973-7847.65321     Document Type: Review

References (33)

1. Toplak G.K. Domace lekovito bilje. Zagreb: Mozaik Kniga; 2005. p. 50-51.
2. Jancic R. Botanika farmaceutika. Beograd: Sluzbeni list SRJ; 2002. p. 247.
3. Tucakov J. Lecenje biljem-fi toterapija. Beograd: Kultura 1971. p. 180-190
4. Vanjkevic SK. Lecenje belim lukom. Beograd: S.K.Vanjkevic 2002. p. 10-17
5. Gorunovic M. Farmakognozija. Beograd: Gorunovic; 2001. p. 672-680
6. Tucakov J. Farmakognozija. Beograd: Naucna knjiga; 1948. p. 278-280
7. Pelagic V. Pelagicev narodni ucitelj. Beograd: Sloboda; 1970. p. 500-502
8. Nikolovski B. Prilozi od istorijata na zdravstvenata kultura na Makedonija. Skopje: MFD; 1995. p. 56-174. Available from: http://www.wikipedia. org/wiki/Garlic. [cited in 2009].
9. Dervendzi V. Sovremeno lekuvanje so lekoviti bilki. 2nd ed. Skopje: Narodna Kniga; 1992. p. 306-307
10. Kovacevic N. Osnovi farmakognozije. Beograd: Licno Izdanje; 2000. p. 170-171
11. Kulevanova S. Farmakognozija. Skopje: Kultura; 2004. p. 417-418
12. Tedeschi P, Maietti A, Boggian M, Vecchiati G, Brandolini V. Fungitoxicity of lyophilized and spray-dried garlic extracts. J Environ Sci Health B 2007;42:795-799
13. Lukic P. Farmakognozija. Beograd: SSO Famaceutski fakultet Beograd; 1985. p. 548-549 Availlable at: http://www.umm.edu/altmed/articles/garlic. [cited in 2009]
14. Availlable at: http://www.news.bbc.co.uk/2/hi/uk-news/wales/mid-/6288012. stm. [cited in 2009].
15. Amagase H, Petesch BL, Matsuura H, Kasuga S, Itakura Y. Intake of garlic and its bioactive components. J Nutr 2001;131:955-962
16. Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996;16:111-124
17. Sovová M, Sova P. In vivo Pharmaceutical importance of Allium sativum L. 5. Hypolipemic effects in vitro and. Ceska Slov Farm 2004;53:117-123
18. Durak I, Kavutcu M, Aytaç B, Avci A, Devrim E, Ozbek H, et al. Effects of garlic extract consumption on blood lipid and oxidant/antioxidant parameters in humans with high blood cholesterol. J Nutr Biochem 2004;15:373-377
19. Isaacsohn JL, Moser M, Stein EA, Dudley K, Davey JA, Liskov E, et al. Garlic powder and plasma lipids and lipoproteins: a multicenter, randomized, placebo-controlled trial. Arch Intern Med 1998;158:1189-1194
20. Superko HR, Krauss RM. Garlic powder, effect on plasma lipids, postprandial lipemia, low-density lipoprotein particle size, high-density lipoprotein subclass distribution and lipoprotein(a). J Am Coll Cardiol 2000;35:321-326
21. Silagy C, Neil A. Garlic as a lipid lowering agent: a meta-analysis. J R Coll Physicians Lond 1994;28:39-45.
22. Reinhart KM, Coleman CI, Teevan C, Vachhani P, White CM. Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother 2008;42:1766-1771
23. Durak I, Oztürk HS, Olcay E, Güven C. Effects of garlic extract supplementation on blood lipid and antioxidant parameters and atherosclerotic plaque formation process in cholesterol-fed rabbits. J Herb Pharmacother 2002;2:19-32.
24. Blumenthal M. The complete German Commission E Monographs, Special expert committee of the German federal institute for drugs and medical devices, Austin; 1998.
25. Ichikawa M, Ryu K, Yoshida J, Ide N, Kodera Y, Sasaoka T, Rosen RT. Identifi cation of six phenylpropanoids from garlic skin as major antioxidants. J Agric Food Chem 2003;51:7313-7317
26. Dhawan V, Jain S. Garlic supplementation prevents oxidative DNA damage in essential hypertension. Mol Cell Biochem 2005;275:85-94.
27. Borek C. Garlic reduces dementia and heart-disease risk. J Nutr 2006;136:810-812
28. Borek C. Antioxidant health effects of aged garlic extracts. J Nutr 2001;131:1010-1015
29. Hassan HT. Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy. Leuk Res 2004;28:667-671
30. Zhang Y, Yao HP, Huang FF, Wu W, Gao Y, Chen ZB, et al. Allicin, a major component of garlic, inhibits apoptosis in vital organs in rats with trauma/hemorrhagic shock. Crit Care Med 2008;36:3226-3232
31. European Pharmacopoeia. 6th Edition, Council of Europe, Strasburg; 2008.
32. USP 31 The United states pharmacopoeia. The United states pharmacopoeial convention. Washington: 2008.
33. British Pharmacopoeia. British Pharmacopoeia commission, London; 2007